跳至主要内容
临床试验/CTRI/2022/04/042044
CTRI/2022/04/042044尚未招募未知

Clinical effectiveness of Concentrated Growth Factor and injectable bioceramic material compared to MTA as pulpotomy agent in Permanent Mature Molar with Symptomatic Irreversible Pulpitis- a randomized controlled clinical trial.

S B Divya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients with symptomatic Irreversible Pulpitis of age 18 to 40 years permanent mature molar teeth with symptomatic irreversible pulpitis
  • 2)Both Maxillary and Mandibular molar teeth.
  • 3) A clinical diagnosis consistent with irreversible pulpitis will be established in all cases based on a history of severe spontaneous lingering pain that could be reproduced by cold testing.
  • 4)Teeth which are tender to percussion can be included but those with periapical lesions, resorption of root must be excluded.

排除标准

  • 1)Patients < 18years of age.
  • 2)Patients of age > 40 years of age
  • 3)Medically compromised patients
  • 4)Pregnant and lactating women.
  • 5)Patients undergoing fixed orthodontic therapy
  • 6)Patients with facial deformity including cleft lip/palate.
  • 7)Teeth with apical periodontitis.
  • 8)Teeth with fracture or crack lines.
  • 9)Teeth with abrasion on the same tooth.

研究者

发起方
S B Divya

相似试验